Funding Update
04 Juni 2009 - 2:32PM
UK Regulatory
TIDMMMG
RNS Number : 3854T
Medical Marketing Int'l Group PLC
04 June 2009
FUNDING UPDATE
4 June 2009 - Medical Marketing International Group plc ("MMI" or the "Company")
(AIM:MMG), the life sciences company focused on the development of drugs for
cancer, today provides an update on the funding arrangements of the Company.
At the time of its interim results in December 2008, MMI announced that it was
funded until the end of June 2009. Following the advancement of the Company's
cost-cutting program, MMI today announces that it now has funds sufficient to
last until late summer. The Board continues to discuss further funding options
and will provide a further update when appropriate.
The Company also reports that it has not yet resolved the outstanding employment
claims of David Best.
Enquiries:
+-----------------------------------------+-----------------------------------------+
| Medical Marketing International Group | Tel: +44 (0) 1223 477 677 |
| plc | |
| Phil Cartmell, Non-executive Chairman | |
| Mark Burton, Chief Technical Officer | |
| Rob Sprawson, Chief Financial Officer | |
+-----------------------------------------+-----------------------------------------+
| | |
+-----------------------------------------+-----------------------------------------+
| FinnCap | Tel: +44 (0)20 7600 1658 |
| Sam Smith/Charlie Cunningham | |
+-----------------------------------------+-----------------------------------------+
| | |
+-----------------------------------------+-----------------------------------------+
| Financial Dynamics | Tel: +44 (0)20 7831 3113 |
| Emma Thompson | |
+-----------------------------------------+-----------------------------------------+
About MMI
Medical Marketing International Group plc ("MMI") is a life sciences company
that identifies, acquires and develops world-class compounds and technologies
for the treatment of cancer. The Company manages the preclinical and early
clinical development of drug candidates before pursuing licensing partners to
manage late-stage development. Please visit www.mmigroup.co.uk for further
information.
Notwithstanding the inclusion on this release by MMI of a website address and/or
another electronic address, MMI does not accept any notices or any other
documents or communication via its website or other electronic address. All such
notices, documents or communication shall be in hard copy format only.
Accordingly the provisions of section 333 Companies Act 2006 allowing persons to
communicate with MMI electronically shall not apply to MMI.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCILFVFRFISIIA
Medical Mktg (LSE:MMG)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Medical Mktg (LSE:MMG)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Medical Mktg (Londoner Börse): 0 Nachrichtenartikel
Weitere Medical Marketing News-Artikel